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The nucleotide sequence of component C9 of rat proteasomes (multicatalytic proteinase complexes) has been determined from a recombinant cDNA 
clone isolated by screening a Reubcr H4TG hepatoma cell cDNA library using synthetic oligodeoxynucleotide probes corresponding to partial 
amino acid sequences of the protein. The predicted sequence of C9 consists of 261 amino acid residues with a calculated molecular weight of 29 496. 
The C9 component is a novel protein, differing from known proteins, but its primary structure resembles those of other proteasome components, 
including C2, C3 and C5, although its similarity to CS is relatively low, suggesting that proteasomes consist of a family of proteins that have evolved 
from a common ancestor. 
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1. INTRODUCTION 
Proteasomes are unusually large multicatalytic pro- 
teinase complexes with a molecular mass of approx- 
imately 750 kDa, which are composed of over 10 
subunits of non-identical polypeptides with similar 
molecular masses of 21-3 1 kDa and different p1 values 
of 3-10 [l-5]. For determining the functions of these 
proteasomal multisubunit complexes, it is essential to 
obtain information about the structure-function rela- 
tionships of individual subunits and the molecular 
mechanism of subunit organization. For this purpose, 
we are attempting to determine the primary structures 
of all the subunits of proteasomes by recombinant 
DNA techniques. So far we have isolated and sequenc- 
ed cDNAs for components C2 [6], C3 [7] and C5 [8] of 
rat liver proteasomes. In this paper, we report the clon- 
ing and sequencing of a full-length cDNA for another 
component, C9, of rat proteasomes. 
of C9 protein were obtained by digestion with lysyl endopeptidase, 
and their amino acid sequences were determined with a gas-phase se- 
quencer (Applied Biosystems, model 477A). and 120A 
phenylthiohydantoin analyzer on-line system [6,7]. A cDNA library 
of Reuber H4TG hepatoma cells was constructed in a phagemid ex- 
pression vector, Bluescript KS+ (Stratagene) as described previously 
[7]. For isolation of cDNAs for component C9, about 30000 
transformants were screened by hybridization with oligodeox- 
yribonucleotide probes (see section 3.2) that had been synthesized in 
an Applied Biosystems Model 380A DNA Synthesizer and labeled at 
their 5 ‘-end with [y-32P]ATP. Colony hybridization was carried out 
by a reported method [a]. DNA sequencing was carried out by the 
dideoxy chain-termination method with a 7-DEAZA Sequencing Kit 
(Takara Shuzo) and Sequenase (Toyobo). Northern blot analysis was 
performed as described before [6] using 10 cg of poly(A)+ mRNA ex- 
tracted from various tissues of rats and a probe (600 bp XhoI-PstI 
fragment of C9 cDNA) labeled by the multiprime DNA labeling 
method with [cu-“P]dCTP. 
3. RESULTS AND DISCUSSION 
3.1. Protein sequencing of component C9 
2. MATERIALS AND METHODS 
Rat liver proteasomes were purified as reported previously [2,4]. 
Component C9 was isolated from the purified proteasomes by 
reversed-phase HPLC on a Cosmosil X4-300 column [5]. Fragments 
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Previously, we reported the separation of multiple 
components of proteasomes from rat liver by reversed- 
phase HPLC [5]. First, 10 major components were 
separated on a Cosmosil 5C4-300 column and named 
component 1 (Cl) to component 10 (ClO) in order of 
their elution. Component C9 was recovered at 53% 
acetonitrile concentration. Fig.1 shows the profiles on 
SDS-PAGE of all the components of rat liver pro- 
teasomes and the isolated component C9. On SDS- 
PAGE analysis, the molecular mass of C9 was deter- 
mined to be 28700 f 700 [5,6]. 
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Fig. 1. Profiles of rat liver proteasomes and isolated component C9 
on SDS-PAGE. Proteasomes (25 pg) and component C9 
(appro~mately 1 Fg) were subjected to SDS-PAGE. M, molecular 
mass markers; P, purified proteasome complexes; C9, isolated C9. 
Proteins were stained with Coomassie brilliant blue. 
The N-terminus of C9 seemed to be blocked, because 
it was not reactive with phenylisothiocyanate. For 
determination of the primary structure of its internal 
region, samples of C9 were reduced, ~-pyridylethylated 
and digested with lysyl endopeptidase. The resulting 
fragments were resolved by reversed-phase HPLC on a 
Chemcosorb 7-ODS-H column (data not shown) and 
their partial primary structures were analyzed by 
automated Edman degradation (solid lines in Fig. 2). 
3.2. Isolation of cDNA clones encoding component C9 
To isolate proteasome cDNA clones more efficiently, 
we constructed a new cDNA library with the phagemid 
Bluescript KS+ vector using poly(A)+ RNAs extracted 
from the H4TG cells 181, because the mRNA levels of 
components C2, and C3 in Reuber H4TG hepatoma 
cells were very much higher than those in normal rat 
liver (Kumatori et al., submitted). We screened this 
library by hybridization with synthetic deox- 
yribonucleotides as probes. For use as probes, we 
selected parts of the sequences of two of the proteolytic 
fragments of C9 with minimum codon ambiguity (Tyr- 
Ile-Gly-Trp-Asp-Lys and Asn-Glu-Asp-jet-Ala-Cys) 
and synthesized their antisense oligonu~leotide se- 
quences, 5 ’ -TTRTCCCANCCDATRTA-3 ’ and 
5 ’ -CANGCCATRTCYTCRTT-3 ’ (N=AGTC, 
D=AGT, Y=TC, R=AG). We first screened about 
30000 colonies of the H4TG cell cDNA library with 48 
mixtures of the former 17mer oligonucleotides, For se- 
cond screening, we used 32 mixtures of the latter 17mer 
oligonucieotides. Ten cDNA clones that gave strongly 
positive signals with both probes were isolated from the 
library by colony hybridization techniques. Of these, 
the clone (about 1.2 kb length including a poly{A) tail) 
that carried the largest cDNA insert was subjected to 
cDNA sequencing. 
Fig. 2. Structure of cDNA for component C9 of rat proteasomes. 
Upper panel: Restriction endonuclease map of cloned cDNA for 
component C9 and sequencing strategy, The solid and open boxes 
show the coding region and 5’- and 3 ‘-non-coding regions, 
respectively. Continuous lines indicate the sequence of the vector, 
Bluescript KS+. The numbers below boxes indicate the nucleotide 
numbers of the first nucleotide of the initiation codon, ATG, and the 
nucleotide before the termination codon, TAG. Sequenced regions 
are shown by horizontal arrows. The sequence of the 5’-end of 
cDNA was determined by direct sequencing of an isolated clone, 
using a primer of the T3 promoter of Bluescript KS+ (dotted arrow). 
Two 17mer oligonucleotides were synthesized as reported previously 
[6] and used as primers for sequencing some regions (dashed arrows). 
Some fragments were obtained by subcloning after cleavages with 
HindHI, Ncol, EcoRV and PvuIi and were sequenced with T3 and 
T7 primers (solid arrows). The bar represents 100 bp. Lower panel: 
Nucleotide sequence of the cDNA encoding component C9 and the 
amino acid sequence deduced from its largest open reading frame. 
Nucleotides are numbered in the 5 ’ to 3 ’ direction, beginning with 
the first residue of the putative initiation methionine codon ‘ATG3. 
The nucleotides on the 5 ’ side are indicated by negative numbers. The 
predicted amino acid sequence of C9 is shown below the nucleotide 
sequence. Amino acid residues are numbered from the N-terminus. 
Continuous lines show the amino acid sequences corresponding to 
those obtained by Edman degradation of the fragments cleaved with 
lysyl endopeptidase. Amino acids shown by broken lines in the 
sequences of K2, and K4 were not identified by chemical analysis. 
The termination codon TAG is doubly underlined with broken lines. 
The possible polyadenylation signal (AATAAA) is doubly underlined 
with continuous lines. 
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Fig. 3. RNA blot hybridization of rat liver C9 cDNA with poly(A)+ 
RNAs from various rat tissues. Poly(A)’ RNAs (10 cg) were used for 
Northern blot analysis. The XhoI-PstI fragment (600 bp) of cloned 
C9 cDNA was used as a probe (Fig. 2). Rat liver (lane 1), kidney (lane 
2), skeletal muscle (lane 3), heart (lane 4), lung (lane S), spleen (lane 
6) and brain (lane 7) were examined. The positions of RNA standards 
(from Bethesda Research Laboratories) are shown (in kilobases) on 
the left. 
3.3. Primary structure deduced from the cDNA 3.4. Expression of the gene for component C9 in 
sequence various rat tissues 
The nucleotide sequence of the C9 cDNA clone was 
determined by the strategy illustrated in Fig. 2 (upper 
panel). The resulting nucleotide sequence of the cDNA 
and the primary structure of the C9 deduced from the 
cDNA sequence are shown in Fig. 2 (lower panel). The 
sequence of 1121 nucleotides included the entire coding 
region and 5 ’ - and 3 ’ -non-coding regions. The 3 ’ -non- 
coding region consisted of 242 nucleotides, excluding 
the poly(A) tail. A putative polyadenylation signal 
(AATAAA), which is common to eukaryotic mRNAs, 
was located 20 nucleotides upstream from the poly(A) 
addition site. Part of the poly(A) sequence (approx- 
imately 90 nucleotides) is seen at the 3 ‘-end of this 
cDNA sequence. The longest open reading frame 
(ORF) is 783 nucieotides long, which corresponds to a 
protein of 261 amino acids. From this deduced se- 
quence, the molecular mass of C9 was calculated to be 
29496. We concluded that ATG, located at nucleotides 
1 to 3, is the initiation codon, because the longest ORF 
is usually thought to be the coding sequence of a pro- 
tein, because a stop codon is present upstream of the 
predicted initiation codon ‘ATG3 for C9 at nucleotides 
- 13 to - 15 (boxed in Fig. 2), and because this ‘ATG3 
is surrounded by a sequence that is similar to the con- 
sensus sequence for translation initiation [9]. Several 
lines of evidence indicated that the amino acid sequence 
shown in Fig. 2 is actually that of C9 of proteasomes: 
(i) the partial sequences of several fragments determin- 
ed chemically were found to be in excellent accordance 
with those deduced from the nucleotide sequence of 
cDNA (solid lines in Fig. 2); (ii) the molecular mass of 
C9 estimated from its amino acid composition (29496) 
To determine the tissue specificity of C9 gene expres- 
sion, we examined the levels of CPspecific mRNA in 
various rat tissues. On Northern blot analysis, the 
mRNAs extracted from various rat tissues gave two 
hybridization bands of about 1.34 kb (Fig. 3). The 
level of mRNA for component C9 varied significantly 
in the different tissues examined, but was very similar 
to those of the mRNAs for components C2 [6], C3 [7] 
and C5 [8]. Moreover, these mRNA levels were fairly 
similar to the absolute tissue contents of proteasomes 
measured by quantitative enzyme immunoassay [2]. 
These results suggest that proteasomes with similar 
subunit compositions are present as large complexes in 
different cells and tissues. 
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previously reported proteins could be found, suggesting 
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that they may have originated from a common 
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